Your browser doesn't support javascript.
loading
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
Togano, Tomiteru; Uemura, Yukari; Asai, Yusuke; Hayakawa, Kayoko; Matsunaga, Nobuaki; Terada, Mari; Ohtsu, Hiroshi; Suzuki, Setsuko; Toyoda, Ako; Hara, Hisao; Sato, Rubuna; Ishikane, Masahiro; Kinoshita-Iwamoto, Noriko; Hangaishi, Akira; Ohmagari, Norio.
Afiliação
  • Togano T; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ttogano@hosp.ncgm.go.jp.
  • Uemura Y; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Asai Y; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hayakawa K; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Matsunaga N; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Terada M; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohtsu H; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Suzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Toyoda A; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hara H; Department of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sato R; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ishikane M; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kinoshita-Iwamoto N; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect Chemother ; 27(10): 1498-1503, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34340930
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article